Healthcare provider profile · identity verified

Arthur Steven Pecora, DO

Emergency Medicine · CAPE MAY COURT HOUSE, NJ · NPI 1023053246

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	582	111
Amlodipine Besylate	Amlodipine Besylate	426	79
Pantoprazole Sodium	Pantoprazole Sodium	419	81
Levothyroxine Sodium	Levothyroxine Sodium	382	65
Metoprolol Succinate	Metoprolol Succinate	288	53
Sertraline Hcl	Sertraline Hcl	255	35
Eliquis	Apixaban	251	43
Divalproex Sodium	Divalproex Sodium	245	41
Furosemide	Furosemide	235	59
Tamsulosin Hcl	Tamsulosin Hcl	229	39
Gabapentin	Gabapentin	227	52
Donepezil Hcl	Donepezil Hcl	209	40
Metoprolol Tartrate	Metoprolol Tartrate	206	38
Trazodone Hcl	Trazodone Hcl	196	40
Memantine Hcl	Memantine Hcl	181	31
Losartan Potassium	Losartan Potassium	170	34
Potassium Chloride	Potassium Chloride	160	32
Metformin Hcl	Metformin Hcl	159	30
Buspirone Hcl	Buspirone Hcl	158	22
Lisinopril	Lisinopril	157	38
Mirtazapine	Mirtazapine	152	25
Famotidine	Famotidine	126	22
Carvedilol	Carvedilol	125	26
Rosuvastatin Calcium	Rosuvastatin Calcium	118	24
Clopidogrel	Clopidogrel Bisulfate	115	25
Xarelto	Rivaroxaban	107	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	105	22
Montelukast Sodium	Montelukast Sodium	100	17
Omeprazole	Omeprazole	97	23
Quetiapine Fumarate	Quetiapine Fumarate	96	24
Duloxetine Hcl	Duloxetine Hcl	93	14
Warfarin Sodium	Warfarin Sodium	88	13
Fluoxetine Hcl	Fluoxetine Hcl	87	12
Allopurinol	Allopurinol	84	suppressed
Oxycodone Hcl	Oxycodone Hcl	83	64
Prednisone	Prednisone	82	31
Hydralazine Hcl	Hydralazine Hcl	77	18
Citalopram Hbr	Citalopram Hydrobromide	75	14
Carbidopa-Levodopa	Carbidopa/Levodopa	74	14
Levetiracetam	Levetiracetam	74	17
Risperidone	Risperidone	71	14
Midodrine Hcl	Midodrine Hcl	66	16
Aripiprazole	Aripiprazole	60	11
Paroxetine Hcl	Paroxetine Hcl	59	suppressed
Olanzapine	Olanzapine	55	suppressed
Baclofen	Baclofen	54	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Atenolol	Atenolol	49	suppressed
Spironolactone	Spironolactone	49	12
Simvastatin	Simvastatin	48	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	42	suppressed
Finasteride	Finasteride	42	12
Albuterol Sulfate	Albuterol Sulfate	41	14
Insulin Lispro	Insulin Lispro	41	19
Metformin Hcl Er	Metformin Hcl	41	suppressed
Myrbetriq	Mirabegron	41	suppressed
Breo Ellipta	Fluticasone/Vilanterol	40	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Ezetimibe	Ezetimibe	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Divalproex Sodium Er	Divalproex Sodium	38	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	38	17
Albuterol Sulfate Hfa	Albuterol Sulfate	36	27
Cephalexin	Cephalexin	36	23
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Memantine Hcl Er	Memantine Hcl	35	suppressed
Timolol Maleate	Timolol Maleate	35	suppressed
Meloxicam	Meloxicam	34	suppressed
Torsemide	Torsemide	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Fluticasone Propionate	Fluticasone Propionate	32	17
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Heparin Sodium	Heparin Sodium,porcine	31	suppressed
Milrinone In 5% Dextrose	Milrinone Lactate/D5w	31	suppressed
Budesonide	Budesonide	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	21
Digoxin	Digoxin	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	27	suppressed
Lamotrigine Odt	Lamotrigine	27	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	14
Clonidine Hcl	Clonidine Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Glimepiride	Glimepiride	25	suppressed
Megestrol Acetate	Megestrol Acetate	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	21
Lamotrigine	Lamotrigine	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Nystatin	Nystatin	23	15
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	22	suppressed
Letrozole	Letrozole	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Austedo	Deutetrabenazine	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Amantadine	Amantadine Hcl	19	suppressed
Cilostazol	Cilostazol	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Methylprednisolone	Methylprednisolone	18	18
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Sulfasalazine	Sulfasalazine	16	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Renvela	Sevelamer Carbonate	15	suppressed
Admelog Solostar	Insulin Lispro	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Nyamyc	Nystatin	14	11
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ondansetron Odt	Ondansetron	13	13
Tramadol Hcl	Tramadol Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Calcium Acetate	Calcium Acetate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error